Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · March 25, 2024

Outcomes in Patients With Metastatic TNBC and Their Association With HER2 and Trop-2 Expression Status

Journal of Clinical Oncology


Additional Info

Journal of Clinical Oncology
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
J. Clin. Oncol 2024 Feb 29;[EPub Ahead of Print], A Bardia, HS Rugo, SM Tolaney, D Loirat, K Punie, M Oliveira, A Brufsky, K Kalinsky, J Cortés, JO Shaughnessy, V Diéras, LA Carey, L Gianni, M Piccart-Gebhart, S Loibl, OK Yoon, Y Pan, S Hofsess, SC Phan, SA Hurvitz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading